ARTICLE | Company News
Eisai deal
September 9, 2013 7:00 AM UTC
Eisai said it granted an undisclosed generics manufacturer non-exclusive U.S. commercialization rights to a generic version of the 23 mg tablet of Alzheimer's disease (AD) drug Aricept donepezil. The...